InvestorsHub Logo

gfp927z

06/26/22 11:54 PM

#151 RE: wow_happens28 #150

>> Ease in <<


Fwiw, the only stock allocation I have right now is a small position in the S+P 500 (SPY). A few weeks ago I decided to start easing back in with 1 share of SPY per day, and am now up to 8 shares, so around $3000. The idea was to keep buying 1 share/day for the rest of the year, and gradually re-build the stock side.

But the temptation will be to take profits during the periodic rallies, so will see what happens. It's now $125 in the green, which isn't much, but it's no fun watching profits evaporate, so will probably sell when this current rally starts to fizzle.

The obvious near term target for the S+P 500 is the 50 MA (4065), so another 4% rise from here. But I'll probably take profits around 4000 if it gets there. I figure the S+P 500 will eventually get down into the 3600-3000 range over the next year, and then the 'averaging back in' strategy can be done more earnestly, and hopefully as a buy/hold.




---

gfp927z

06/27/22 11:03 AM

#152 RE: wow_happens28 #150

Fwiw, it's probably too early, but I decided to sell the rally and take profits. A 3.7% gain over two weeks isn't too shabby, all things considered. The rally might have more to go, but in a bear market the general rule is to sell the rallies.


---

gfp927z

06/27/22 11:49 AM

#154 RE: wow_happens28 #150

Looks like RIBT is testing the 50 MA, so will be interesting to see what happens next. There has been a considerable amount of momentum built up over the last 6 months, but looks like the volume has been trailing off after peaking in May. You said they need to trade over 1.00 for a week or so by Sept to avoid delisting, reverse spilt, etc, so could be various factors at work driving the stock's movements.

BABYF has been a dog, but at some point there should be a dead cat bounce. A lot of 'oy veys' lately from followers of this stock lol..

SURG - no signs of buying from the index funds, but I wonder if they bought in earlier, during that May 23 high volume day (?)

AXSM - a biotech I've followed loosely for several years (see next post). No position, but should be interesting. They have a new drug for depression up for approval, but the FDA has been stonewalling for some reason. I figure the FDA is using the current lack of effective depression treatments as a key rationale for getting the various 'psych-meds', ketamine derivatives, Psilocybins, etc legalized and on the market under the guise of medical treatments. Hence the FDA is stonewalling on other more traditional depression med programs.




---